SAN FRANCISCO, May 7 - Caliper Technologies today reported decreased revenues for the first quarter.
Total revenue for the quarter ended March 31 was $7 million compared with $9.8 million in the year-ago period.
Last year's first quarter revenue included a $5 million licensing fee from Aclara BioSciences as part of a litigation statement, Caliper said.
The net loss for the quarter was $9.7 million, or $.40 per share, compared to an income of $26.4 million, or $1.03 a share, for the same period a year ago. Included in 2001 first quarter income was a $27.5 million settlement from Aclara BioSciences. Excluding that payment, net loss for the first quarter of 2001 was $1.1 million, or $.05 a share, according to the company.
R&D spending for the quarter rose to approximately $11 million from $8.8 million for the year-ago period.
The company said it had $151.3 million in cash, cash equivalents, and short-term marketable securities as of March 31.